We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Events

17 Jun 2026 - 19 Jun 2026

MRL Changes Name to Focus Technologies

By HospiMedica staff writers
Posted on 17 May 2001
MRL Diagnostics (Herndon, VA, USA) has changed its name to Focus Technologies, Inc. More...
The company began as a reference laboratory performing esoteric microbiology testing for other laboratories and has grown to become a global leader in infectious disease products and services, serving the international healthcare community from its European base in Hilversum, The Netherlands.

An ISO 9001 certified company, Focus Technologies manufactures and distributes diagnostics test kits for rare and emerging diseases and is the developer of The Surveillance Network (TSN), the global antimicrobial surveillance database. Within the anti-infective pharmaceutical market, Focus has become established as a premier research partner. The new name, says the company, was chosen as part of a strategic move to unite its different business strengths in one entity.

"We have expanded our capabilities over the course of more than two decades. The company needed a name that truly reflects all aspects of our business and our commitment to technology,” said Laurence R. McCarthy, Ph.D., president and CEO of Focus Technologies.




Related Links:
Focus Technologies

Gold Member
Aspiration System
VACUSAFE
Online QC Software
Acusera 24•7
Chromogenic Culture System
InTray™ COLOREX™ ECC
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers use a novel immobilized liposome-bound gel beads method to measure CEC levels and their association with cardiovascular risks (Photo courtesy of Institute of Science Tokyo)

Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features

Unstable coronary plaques are difficult to identify before they trigger acute cardiovascular events. Standard high-density lipoprotein (HDL) measurements do not always capture how well HDL particles function... Read more

Pathology

view channel
Image: Overview of the uncertainty-aware lensfree computational pathology platform for automated HER2 assessment. A compact lensfree holographic imaging system captures diffraction patterns from immunohistochemically stained breast tissue samples, which are computationally reconstructed and analyzed using deep neural networks with Bayesian uncertainty quantification. (Photo courtesy of Ozcan Lab, UCLA)

Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer

Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.